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Results and Conclusions
There was a delay of aging in the strain WS8105-1C-R300cisPt
(resistant to Cisplatin) and in the strain WS8105-1C-R 0.158 Bleo
(resistant to Bleomycin), with respect to the wild type.
The delay in replicative aging started from generation 100, where
there were some differences of the strain WS8105-1C-R300cisPt
with the wild strain and a marked difference between strain
WS8105-1C-R 0.158 Bleo and the wild strain. Due to the analysis is
qualitative and purely visual, we can say that the delay is manifestly
evident in generation 175.
In conclusion, the strain WS8105-1C-R300cisPt and the strain
WS8105-1C-R 0.158 Bleo present an increase in the replicative life
cycle, producing a delay in aging after 100 generations. This fact
suggests that it is possible that there are common cellular and
molecular mechanisms between the acquisition of resistance to
these drugs and the delay in replicative aging that could be
cumulative into new generations of cells.
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Introduction
One of the main reasons why cancer
treatments fail is the development of
resistance to antineoplastic drugs by cancer
cells. This is a very serious problem as it can
lead to recurrence of the disease and even
death.
Aging itself is the leading risk factor for an
array of diseases that increasingly plague the
world population. The replicative aging is
defined as the number of daughter cells that
a progenitor can generate during its life. Due
to its characteristics it is used as a biological
model for the study of aging in mitotically
active tissues.
There are researchs that reveal a
relationship between acquired resistance to
antineoplastic drugs and aging.
Because of its well-characterized genome, S.
cerevisiae will continue to serve as a leading
model organism for studying pathways
relevant to aging and acquired resistance to
antineoplastic drugs. Therefore, the
identification of genes involved in senescence
could have a potential therapeutic utility for
the prediction and/or prevention of
resistance to antineoplastic drugs.
Objectives
The aim of this work is to study the
relationship between replicative aging and
acquired resistance to Cisplatin and
Bleomycin in the yeast Saccharomyces
cerevisiae.
Material and methods
Yeast strain and culture medium
The experiments were carried out with the
haploid yeast strain Saccharomyces cerevisiae
WS8105-1C (genotype: MATalpha, ade2, arg4-17,
trp1-289, ura3-52), with the resistant haploid
yeast strain to cisplatin Saccharomyces cerevisiae
WS8105-1C-R300cisPt and with the resistant
haploid yeast strain to bleomycin Saccharomyces
cerevisiae WS8105-1C-R 0.158 Bleo. Yeast cells
were grown in a solid medium of YPD (1 % Bacto-
yeast extract, 2 % Bacto-peptone, 2 % dextrose
and 2 % Bacto-agar).
Experimental protocol
A loop of cells was spreaded following a square
pattern onto YPD plates. Then, the samples were
incubated during 5 days at 30°C, and next the
samples were seeded. The same protocol was
carried out 9 times (9 phases). Each phase
represents approximately 25 generations;
therefore, it was obtained approximately until
generation 225.
Cells generations in replicative aging.
wt: wild strain (control). WS8105-1C-R300cisPt: resistant to Cisplatin.
WS8105-1C-R 0.158 Bleo: resistant to Bleomycin.
Correlation between Cisplatin and Bleomycin resistance, and delay in aging
